[HTML][HTML] Estimating global, regional, and national daily and cumulative infections with SARS-CoV-2 through Nov 14, 2021: a statistical analysis
Background Timely, accurate, and comprehensive estimates of SARS-CoV-2 daily infection
rates, cumulative infections, the proportion of the population that has been infected at least …
rates, cumulative infections, the proportion of the population that has been infected at least …
Seroprevalence of anti-SARS-CoV-2 antibodies 6 months into the vaccination campaign in Geneva, Switzerland, 1 June to 7 July 2021
Background Up-to-date seroprevalence estimates are critical to describe the SARS-CoV-2
immune landscape and to guide public health decisions. Aim We estimate seroprevalence …
immune landscape and to guide public health decisions. Aim We estimate seroprevalence …
Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection
J Van Elslande, M Oyaert, N Lorent… - … and infectious disease, 2022 - Elsevier
We retrospectively compared the long-term evolution of IgG anti-spike (S) and anti-
nucleocapsid (N) levels (Abbott immunoassays) in 116 non-severe and 115 severe SARS …
nucleocapsid (N) levels (Abbott immunoassays) in 116 non-severe and 115 severe SARS …
Seroprevalence of anti-SARS-CoV-2 antibodies and cross-variant neutralization capacity after the Omicron BA. 2 wave in Geneva, Switzerland: a population-based …
Background More than two years into the COVID-19 pandemic, most of the population has
developed anti-SARS-CoV-2 antibodies from infection and/or vaccination. However, public …
developed anti-SARS-CoV-2 antibodies from infection and/or vaccination. However, public …
[HTML][HTML] Dynamics of SARS-CoV-2 seroassay sensitivity: a systematic review and modelling study
Background Serological surveys have been the gold standard to estimate numbers of SARS-
CoV-2 infections, the dynamics of the epidemic, and disease severity. Serological assays …
CoV-2 infections, the dynamics of the epidemic, and disease severity. Serological assays …
Persistent humoral immune response in youth throughout the COVID-19 pandemic: Prospective school-based cohort study
Understanding the development of humoral immune responses of children and adolescents
to SARS-CoV-2 is essential for designing effective public health measures. Here we …
to SARS-CoV-2 is essential for designing effective public health measures. Here we …
Enzyme-linked immunosorbent assay: an adaptable methodology to study SARS-CoV-2 humoral and cellular immune responses
The Enzyme-Linked Immunosorbent Assay is a versatile technique, which can be used for
several applications. It has enormously contributed to the study of infectious diseases. This …
several applications. It has enormously contributed to the study of infectious diseases. This …
Long term anti-SARS-CoV-2 antibody kinetics and correlate of protection against Omicron BA. 1/BA. 2 infection
Binding antibody levels against SARS-CoV-2 have shown to be correlates of protection
against infection with pre-Omicron lineages. This has been challenged by the emergence of …
against infection with pre-Omicron lineages. This has been challenged by the emergence of …
The serological sciences network (SeroNet) for COVID-19: depth and breadth of serology assays and plans for assay harmonization
ABSTRACT In October 2020, the National Cancer Institute (NCI) Serological Sciences
Network (SeroNet) was established to study the immune response to COVID-19, and “to …
Network (SeroNet) was established to study the immune response to COVID-19, and “to …
A population-based serological study of post-COVID syndrome prevalence and risk factors in children and adolescents
Post-COVID syndrome remains poorly studied in children and adolescents. Here, we aimed
to investigate the prevalence and risk factors of pediatric post-COVID in a population-based …
to investigate the prevalence and risk factors of pediatric post-COVID in a population-based …